SPARK
Funded Partner
SPARK has a special focus on the often-neglected diseases, including those in the area of Child and Maternal Health. Thanks to funding from the Stanford Maternal and Child Health Research Institute, 18 projects in this area have reached the clinic or commercial sectors.
SPARK is a unique partnership between the University and industry experts. Building upon Stanford’s tradition of technological innovation and entrepreneurship, Chemical and Systems Biology Professor, Daria Mochly-Rosen, founded the SPARK program, and joined by Professor Kevin Grimes later in the first year, to provide a cost-effective model to generate proof of concept using out-of-the-box academic approaches combined with industry standards.
SPARK provides access to specialized knowledge and technical expertise regarding drug and diagnostic development, dedicated core laboratory facilities, and sources of funding to support translational efforts.
FY 2024 Awards
Janene Fuerch, MD
Clinical Associate Professor, Pediatrics (Neonatal and Developmental Medicine)
Study Title: A Pharmacologic Approach to Prevent Severe Perineal Lacerations During Vaginal Delivery
Everett Meyer, MD
Associate Professor, Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Study Title: Anti-CD3 T Cell Depletion with OrthoCD3 Shielding of Regulatory T Cells
Jean Tang, MD, PhD
Professor, Dermatology
Study Title: Hypertonic Hydrogel for the Treatment of Pediatric Cutaneous Pyogenic Granuloma
Gary Darmstadt, MD
Professor, Pediatrics (Neonatal and Developmental Medicine)
Study Title: Optimized Emollient Mixture for Enhanced Skin Barrier Function and Health of Preterm Infants
Joyce Teng, MD, PhD
Professor, Dermatology
Study Title: Pilot Study Using topical Statins for the Treatment of Infantile Hemangioma